Literature DB >> 33742522

Impact of Wideband Late Gadolinium Enhancement Cardiac Magnetic Resonance Imaging on Device-Related Artifacts in Different Implantable Cardioverter-Defibrillator Types.

Amita Singh1, Wensu Chen1,2, Hena N Patel1, Nazia Alvi1, Keigo Kawaji1,3, Stephanie A Besser1, Roderick Tung1, Jiangang Zou2, Roberto M Lang1, Victor Mor-Avi1, Amit R Patel1.   

Abstract

BACKGROUND: Late gadolinium enhancement (LGE) imaging in patients with implantable cardioverter-defibrillators (ICD) is limited by device-related artifacts (DRA). The use of wideband (WB) LGE protocols improves LGE images, but their efficacy with different ICD types is not well known.
PURPOSE: To assess the effects of WB LGE imaging on DRA in different non-MR conditional ICD subtypes. STUDY TYPE: Retrospective. POPULATION: A total of 113 patients undergoing cardiac magnetic resonance imaging with three ICD subtypes: transvenous (TV-ICD, N = 48), cardiac-resynchronization therapy device (CRT-D, N = 48), and subcutaneous (S-ICD, N = 17). FIELD STRENGTH/SEQUENCE: 5 T scanner, standard LGE, and WB LGE imaging with a phase-sensitive inversion recovery segmented gradient echo sequence. ASSESSMENT: DRA burden was defined as the number of artifact-positive short-axis LGE slices as percentage of the total number of short-axis slices covering the left ventricle from based to apex, and was determined for WB and standard LGE studies for each patient. Additionally, artifact area on each slice was quantified. STATISTICAL TESTS: Shapiro-Wilks, Kruskal-Wallis analysis of variance, Dunn tests with Bonferroni correction, and Mann-Whitney U-test.
RESULTS: In patients with TV-ICD, DRA burden was significantly reduced and nearly eliminated with WB LGE compared to standard LGE imaging (median [interquartile range]: 0 [0-7]% vs. 18 [0-50]%, P < 0.05), but WB imaging had less of an impact on DRA in the CRT-D (8 [0-23]% vs. 16 [0-45]%, p = 0.12) and S-ICD (60 [15-71]% vs. 67 [50-92]%, P = 0.09) patients. Residual DRA was significantly greater (P < 0.05) for S-ICD compared to other device types with WB LGE imaging, despite the generators of all three ICD types having similar proximity to the heart. The area of S-ICD associated DRA was smaller with WB LGE (P < 0.001) than with standard LGE imaging and the artifacts had different characteristics (dark signal void instead of a bright hyperenhancement artifact). DATA
CONCLUSION: Although WB LGE imaging reduced the burden of DRA caused by S-ICD, the residual artifact was greater than that observed with TV-ICD and CRT-D devices. Further developments are needed to better resolve S-ICD artifacts. LEVEL OF EVIDENCE: 1 TECHNICAL EFFICACY: STAGE: 5.
© 2021 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  cardiac magnetic resonance; heart failure; implantable cardioverter-defibrillator; ventricular tachycardia

Mesh:

Substances:

Year:  2021        PMID: 33742522      PMCID: PMC9034356          DOI: 10.1002/jmri.27608

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  23 in total

1.  Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: best practice and real-world experience.

Authors:  Timm Seewöster; Susanne Löbe; Sebastian Hilbert; Andreas Bollmann; Philipp Sommer; Frank Lindemann; Justinas Bacevičius; Katharina Schöne; Sergio Richter; Michael Döring; Ingo Paetsch; Gerhard Hindricks; Cosima Jahnke
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

2.  Clinical impact of cardiovascular magnetic resonance with optimized myocardial scar detection in patients with cardiac implantable devices.

Authors:  Anish N Bhuva; Peter Kellman; Adam Graham; Manish Ramlall; Redha Boubertakh; Patricia Feuchter; Angela Hawkins; Martin Lowe; Pier D Lambiase; Neha Sekhri; Richard J Schilling; James C Moon; Charlotte H Manisty
Journal:  Int J Cardiol       Date:  2019-01-04       Impact factor: 4.164

3.  Feasibility of Cardiac Magnetic Resonance Wideband Protocol in Patients With Implantable Cardioverter Defibrillators and Its Utility for Defining Scar.

Authors:  Amita Singh; Keigo Kawaji; Neha Goyal; Noreen T Nazir; Andrew Beaser; Virginia O'Keefe-Baker; Karima Addetia; Roderick Tung; Peng Hu; Victor Mor-Avi; Amit R Patel
Journal:  Am J Cardiol       Date:  2019-01-31       Impact factor: 2.778

Review 4.  Cardiac Imaging in Patients With Ventricular Tachycardia.

Authors:  Saagar Mahida; Frédéric Sacher; Rémi Dubois; Maxime Sermesant; Frank Bogun; Michel Haïssaguerre; Pierre Jaïs; Hubert Cochet
Journal:  Circulation       Date:  2017-12-19       Impact factor: 29.690

5.  Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: a device-dependent imaging strategy for improved image quality.

Authors:  Sebastian Hilbert; Cosima Jahnke; Susanne Loebe; Sabrina Oebel; Alexander Weber; Ricardo Spampinato; Sergio Richter; Michael Doering; Andreas Bollmann; Philipp Sommer; Gerhard Hindricks; Ingo Paetsch
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2018-09-01       Impact factor: 6.875

6.  Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator.

Authors:  Robert J Russo; Heather S Costa; Patricia D Silva; Jeffrey L Anderson; Aysha Arshad; Robert W W Biederman; Noel G Boyle; Jennifer V Frabizzio; Ulrika Birgersdotter-Green; Steven L Higgins; Rachel Lampert; Christian E Machado; Edward T Martin; Andrew L Rivard; Jason C Rubenstein; Raymond H M Schaerf; Jennifer D Schwartz; Dipan J Shah; Gery F Tomassoni; Gail T Tominaga; Allison E Tonkin; Seth Uretsky; Steven D Wolff
Journal:  N Engl J Med       Date:  2017-02-23       Impact factor: 91.245

7.  Association of preprocedural cardiac magnetic resonance imaging with outcomes of ventricular tachycardia ablation in patients with idiopathic dilated cardiomyopathy.

Authors:  Konstantinos C Siontis; Hyungjin Myra Kim; Ghaith Sharaf Dabbagh; Rakesh Latchamsetty; Jadranka Stojanovska; Krit Jongnarangsin; Fred Morady; Frank M Bogun
Journal:  Heart Rhythm       Date:  2017-06-09       Impact factor: 6.343

8.  Value of Cardiac Magnetic Resonance Imaging in Patients With Failed Ablation Procedures for Ventricular Tachycardia.

Authors:  Mario Njeim; Miki Yokokawa; Luba Frank; Thomas Crawford; Eric Good; Fred Morady; Frank Bogun
Journal:  J Cardiovasc Electrophysiol       Date:  2015-11-06

9.  Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.

Authors:  Alex J A McLELLAN; Andris H Ellims; Sandeep Prabhu; Alex Voskoboinik; Leah M Iles; James L Hare; David M Kaye; Ivan Macciocca; Justin A Mariani; Jonathan M Kalman; Andrew J Taylor; Peter M Kistler
Journal:  J Cardiovasc Electrophysiol       Date:  2016-03-14

10.  Prognostic value role of radiofrequency lesion size by cardiac magnetic resonance imaging on outcomes of ablation in patients with ischemic scar-related ventricular tachycardia: A single center pilot study.

Authors:  Tümer Erdem Guler; Kivanç Yalin; Tolga Aksu; Ebru Golcuk; Sukru Sanli; Ahmet Kaya Bilge; Kamil Adalet
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

View more
  2 in total

1.  Reducing cardiac implantable electronic device-induced artefacts in cardiac magnetic resonance imaging.

Authors:  Aino-Maija Vuorinen; Lauri Lehmonen; Jarkko Karvonen; Miia Holmström; Sari Kivistö; Touko Kaasalainen
Journal:  Eur Radiol       Date:  2022-08-27       Impact factor: 7.034

Review 2.  Cardiac Magnetic Resonance Imaging for the Diagnosis of Infective Endocarditis in the COVID-19 Era.

Authors:  Sapan Bhuta; Neha J Patel; Jacob A Ciricillo; Michael N Haddad; Waleed Khokher; Mohammed Mhanna; Mitra Patel; Cameron Burmeister; Hazem Malas; Joel A Kammeyer
Journal:  Curr Probl Cardiol       Date:  2022-09-17       Impact factor: 16.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.